Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 21 |
NetGPI | no | yes: 0, no: 21 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A4HQF5
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 22 |
GO:0005488 | binding | 1 | 22 |
GO:0097159 | organic cyclic compound binding | 2 | 22 |
GO:1901363 | heterocyclic compound binding | 2 | 22 |
GO:0000175 | 3'-5'-RNA exonuclease activity | 7 | 3 |
GO:0003824 | catalytic activity | 1 | 3 |
GO:0004518 | nuclease activity | 4 | 3 |
GO:0004527 | exonuclease activity | 5 | 3 |
GO:0004532 | RNA exonuclease activity | 5 | 3 |
GO:0004535 | poly(A)-specific ribonuclease activity | 8 | 1 |
GO:0004540 | RNA nuclease activity | 4 | 3 |
GO:0008408 | 3'-5' exonuclease activity | 6 | 3 |
GO:0016787 | hydrolase activity | 2 | 3 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 3 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 3 |
GO:0016896 | RNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 3 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 3 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 3 |
GO:0003723 | RNA binding | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 490 | 494 | PF00656 | 0.351 |
CLV_NRD_NRD_1 | 225 | 227 | PF00675 | 0.330 |
CLV_NRD_NRD_1 | 249 | 251 | PF00675 | 0.348 |
CLV_NRD_NRD_1 | 321 | 323 | PF00675 | 0.332 |
CLV_NRD_NRD_1 | 444 | 446 | PF00675 | 0.614 |
CLV_NRD_NRD_1 | 71 | 73 | PF00675 | 0.330 |
CLV_PCSK_KEX2_1 | 224 | 226 | PF00082 | 0.310 |
CLV_PCSK_KEX2_1 | 320 | 322 | PF00082 | 0.332 |
CLV_PCSK_KEX2_1 | 461 | 463 | PF00082 | 0.395 |
CLV_PCSK_KEX2_1 | 54 | 56 | PF00082 | 0.282 |
CLV_PCSK_PC1ET2_1 | 224 | 226 | PF00082 | 0.323 |
CLV_PCSK_PC1ET2_1 | 461 | 463 | PF00082 | 0.271 |
CLV_PCSK_PC1ET2_1 | 54 | 56 | PF00082 | 0.289 |
CLV_PCSK_SKI1_1 | 133 | 137 | PF00082 | 0.276 |
CLV_PCSK_SKI1_1 | 244 | 248 | PF00082 | 0.238 |
CLV_PCSK_SKI1_1 | 281 | 285 | PF00082 | 0.337 |
CLV_PCSK_SKI1_1 | 462 | 466 | PF00082 | 0.315 |
CLV_PCSK_SKI1_1 | 499 | 503 | PF00082 | 0.437 |
CLV_PCSK_SKI1_1 | 96 | 100 | PF00082 | 0.154 |
DEG_APCC_DBOX_1 | 498 | 506 | PF00400 | 0.253 |
DEG_APCC_DBOX_1 | 95 | 103 | PF00400 | 0.539 |
DEG_MDM2_SWIB_1 | 239 | 247 | PF02201 | 0.447 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.362 |
DOC_CYCLIN_RxL_1 | 240 | 249 | PF00134 | 0.389 |
DOC_CYCLIN_RxL_1 | 496 | 506 | PF00134 | 0.261 |
DOC_MAPK_DCC_7 | 96 | 104 | PF00069 | 0.469 |
DOC_MAPK_gen_1 | 231 | 239 | PF00069 | 0.539 |
DOC_MAPK_gen_1 | 469 | 476 | PF00069 | 0.457 |
DOC_MAPK_MEF2A_6 | 96 | 104 | PF00069 | 0.469 |
DOC_MIT_MIM_1 | 478 | 487 | PF04212 | 0.403 |
DOC_PP1_RVXF_1 | 203 | 209 | PF00149 | 0.560 |
DOC_PP1_RVXF_1 | 233 | 240 | PF00149 | 0.455 |
DOC_PP1_RVXF_1 | 460 | 467 | PF00149 | 0.246 |
DOC_PP2B_LxvP_1 | 97 | 100 | PF13499 | 0.469 |
DOC_PP4_FxxP_1 | 43 | 46 | PF00568 | 0.444 |
DOC_USP7_MATH_1 | 100 | 104 | PF00917 | 0.354 |
DOC_USP7_MATH_1 | 160 | 164 | PF00917 | 0.507 |
DOC_USP7_MATH_1 | 388 | 392 | PF00917 | 0.501 |
DOC_USP7_UBL2_3 | 244 | 248 | PF12436 | 0.403 |
DOC_USP7_UBL2_3 | 349 | 353 | PF12436 | 0.539 |
DOC_WW_Pin1_4 | 268 | 273 | PF00397 | 0.409 |
LIG_14-3-3_CanoR_1 | 445 | 450 | PF00244 | 0.494 |
LIG_14-3-3_CanoR_1 | 462 | 467 | PF00244 | 0.326 |
LIG_14-3-3_CanoR_1 | 469 | 475 | PF00244 | 0.409 |
LIG_14-3-3_CanoR_1 | 482 | 487 | PF00244 | 0.466 |
LIG_14-3-3_CanoR_1 | 72 | 79 | PF00244 | 0.518 |
LIG_BRCT_BRCA1_1 | 493 | 497 | PF00533 | 0.499 |
LIG_Clathr_ClatBox_1 | 394 | 398 | PF01394 | 0.451 |
LIG_FHA_1 | 115 | 121 | PF00498 | 0.535 |
LIG_FHA_1 | 138 | 144 | PF00498 | 0.512 |
LIG_FHA_1 | 406 | 412 | PF00498 | 0.408 |
LIG_FHA_1 | 417 | 423 | PF00498 | 0.390 |
LIG_FHA_1 | 463 | 469 | PF00498 | 0.395 |
LIG_FHA_2 | 288 | 294 | PF00498 | 0.494 |
LIG_FHA_2 | 30 | 36 | PF00498 | 0.471 |
LIG_FHA_2 | 308 | 314 | PF00498 | 0.540 |
LIG_GBD_Chelix_1 | 166 | 174 | PF00786 | 0.154 |
LIG_GBD_Chelix_1 | 176 | 184 | PF00786 | 0.244 |
LIG_GBD_Chelix_1 | 202 | 210 | PF00786 | 0.269 |
LIG_GBD_Chelix_1 | 366 | 374 | PF00786 | 0.310 |
LIG_LIR_Apic_2 | 331 | 337 | PF02991 | 0.460 |
LIG_LIR_Apic_2 | 41 | 46 | PF02991 | 0.440 |
LIG_LIR_Gen_1 | 23 | 31 | PF02991 | 0.430 |
LIG_LIR_Gen_1 | 276 | 284 | PF02991 | 0.514 |
LIG_LIR_Gen_1 | 377 | 386 | PF02991 | 0.344 |
LIG_LIR_Gen_1 | 4 | 13 | PF02991 | 0.517 |
LIG_LIR_Gen_1 | 494 | 505 | PF02991 | 0.272 |
LIG_LIR_Gen_1 | 59 | 69 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 23 | 27 | PF02991 | 0.398 |
LIG_LIR_Nem_3 | 276 | 280 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 356 | 362 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 377 | 382 | PF02991 | 0.327 |
LIG_LIR_Nem_3 | 4 | 9 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 494 | 500 | PF02991 | 0.394 |
LIG_LIR_Nem_3 | 59 | 64 | PF02991 | 0.452 |
LIG_MAD2 | 244 | 252 | PF02301 | 0.539 |
LIG_Pex14_2 | 239 | 243 | PF04695 | 0.453 |
LIG_SH2_CRK | 334 | 338 | PF00017 | 0.519 |
LIG_SH2_STAP1 | 131 | 135 | PF00017 | 0.545 |
LIG_SH2_STAP1 | 188 | 192 | PF00017 | 0.444 |
LIG_SH2_STAP1 | 359 | 363 | PF00017 | 0.455 |
LIG_SH2_STAP1 | 418 | 422 | PF00017 | 0.236 |
LIG_SH2_STAT3 | 131 | 134 | PF00017 | 0.354 |
LIG_SH2_STAT3 | 201 | 204 | PF00017 | 0.518 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.497 |
LIG_SH2_STAT5 | 277 | 280 | PF00017 | 0.546 |
LIG_SH2_STAT5 | 393 | 396 | PF00017 | 0.456 |
LIG_SH2_STAT5 | 418 | 421 | PF00017 | 0.352 |
LIG_SH2_STAT5 | 87 | 90 | PF00017 | 0.457 |
LIG_SH3_3 | 31 | 37 | PF00018 | 0.476 |
LIG_SH3_3 | 7 | 13 | PF00018 | 0.526 |
LIG_SUMO_SIM_par_1 | 8 | 14 | PF11976 | 0.491 |
LIG_TRAF2_1 | 125 | 128 | PF00917 | 0.470 |
LIG_TRFH_1 | 334 | 338 | PF08558 | 0.539 |
LIG_UBA3_1 | 501 | 509 | PF00899 | 0.248 |
MOD_CK1_1 | 457 | 463 | PF00069 | 0.498 |
MOD_CK1_1 | 492 | 498 | PF00069 | 0.563 |
MOD_CK2_1 | 211 | 217 | PF00069 | 0.502 |
MOD_CK2_1 | 307 | 313 | PF00069 | 0.539 |
MOD_GlcNHglycan | 162 | 165 | PF01048 | 0.275 |
MOD_GlcNHglycan | 386 | 389 | PF01048 | 0.459 |
MOD_GlcNHglycan | 390 | 393 | PF01048 | 0.481 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.333 |
MOD_GSK3_1 | 133 | 140 | PF00069 | 0.514 |
MOD_GSK3_1 | 287 | 294 | PF00069 | 0.482 |
MOD_GSK3_1 | 307 | 314 | PF00069 | 0.498 |
MOD_GSK3_1 | 324 | 331 | PF00069 | 0.548 |
MOD_GSK3_1 | 384 | 391 | PF00069 | 0.400 |
MOD_GSK3_1 | 445 | 452 | PF00069 | 0.468 |
MOD_GSK3_1 | 478 | 485 | PF00069 | 0.513 |
MOD_N-GLC_1 | 405 | 410 | PF02516 | 0.463 |
MOD_N-GLC_1 | 89 | 94 | PF02516 | 0.312 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.424 |
MOD_NEK2_1 | 114 | 119 | PF00069 | 0.492 |
MOD_NEK2_1 | 170 | 175 | PF00069 | 0.458 |
MOD_NEK2_1 | 208 | 213 | PF00069 | 0.495 |
MOD_NEK2_1 | 246 | 251 | PF00069 | 0.456 |
MOD_NEK2_1 | 284 | 289 | PF00069 | 0.526 |
MOD_NEK2_1 | 307 | 312 | PF00069 | 0.415 |
MOD_NEK2_1 | 411 | 416 | PF00069 | 0.309 |
MOD_NEK2_1 | 470 | 475 | PF00069 | 0.407 |
MOD_NEK2_1 | 491 | 496 | PF00069 | 0.444 |
MOD_PIKK_1 | 38 | 44 | PF00454 | 0.472 |
MOD_PKA_1 | 445 | 451 | PF00069 | 0.407 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.531 |
MOD_Plk_1 | 1 | 7 | PF00069 | 0.367 |
MOD_Plk_1 | 328 | 334 | PF00069 | 0.376 |
MOD_Plk_1 | 405 | 411 | PF00069 | 0.409 |
MOD_Plk_2-3 | 217 | 223 | PF00069 | 0.444 |
MOD_Plk_4 | 100 | 106 | PF00069 | 0.499 |
MOD_Plk_4 | 134 | 140 | PF00069 | 0.518 |
MOD_Plk_4 | 287 | 293 | PF00069 | 0.510 |
MOD_Plk_4 | 311 | 317 | PF00069 | 0.537 |
MOD_Plk_4 | 405 | 411 | PF00069 | 0.415 |
MOD_ProDKin_1 | 268 | 274 | PF00069 | 0.409 |
MOD_SUMO_rev_2 | 276 | 283 | PF00179 | 0.502 |
MOD_SUMO_rev_2 | 377 | 385 | PF00179 | 0.409 |
TRG_DiLeu_BaEn_1 | 279 | 284 | PF01217 | 0.354 |
TRG_DiLeu_BaLyEn_6 | 496 | 501 | PF01217 | 0.559 |
TRG_ENDOCYTIC_2 | 277 | 280 | PF00928 | 0.461 |
TRG_ENDOCYTIC_2 | 61 | 64 | PF00928 | 0.459 |
TRG_ER_diArg_1 | 225 | 228 | PF00400 | 0.502 |
TRG_ER_diArg_1 | 320 | 322 | PF00400 | 0.528 |
TRG_NES_CRM1_1 | 2 | 14 | PF08389 | 0.291 |
TRG_Pf-PMV_PEXEL_1 | 225 | 230 | PF00026 | 0.299 |
TRG_Pf-PMV_PEXEL_1 | 445 | 450 | PF00026 | 0.560 |
TRG_Pf-PMV_PEXEL_1 | 499 | 503 | PF00026 | 0.260 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P603 | Leptomonas seymouri | 54% | 99% |
A0A0N1ILJ1 | Leptomonas seymouri | 26% | 84% |
A0A0S4IJ60 | Bodo saltans | 24% | 100% |
A0A0S4IMW3 | Bodo saltans | 24% | 100% |
A0A0S4J225 | Bodo saltans | 34% | 70% |
A0A1X0NLC6 | Trypanosomatidae | 34% | 99% |
A0A1X0NXI3 | Trypanosomatidae | 27% | 84% |
A0A3Q8ICI3 | Leishmania donovani | 26% | 85% |
A0A3R7K5K5 | Trypanosoma rangeli | 33% | 98% |
A0A3S7XC77 | Leishmania donovani | 74% | 100% |
A0A422N5N5 | Trypanosoma rangeli | 27% | 86% |
A4HCS6 | Leishmania braziliensis | 26% | 100% |
A4I0A0 | Leishmania infantum | 26% | 85% |
A4IC91 | Leishmania infantum | 75% | 100% |
B2RXZ1 | Mus musculus | 24% | 96% |
C9ZV58 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 87% |
D0A3T2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 100% |
E9AU71 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 75% | 100% |
E9AW65 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 86% |
H9JAQ7 | Bombyx mori | 26% | 96% |
O94386 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 23% | 100% |
O95453 | Homo sapiens | 25% | 80% |
P69341 | Bos taurus | 25% | 80% |
Q21412 | Caenorhabditis elegans | 25% | 90% |
Q4Q0C3 | Leishmania major | 75% | 100% |
Q4QBB3 | Leishmania major | 27% | 100% |
Q5R6R6 | Pongo abelii | 25% | 98% |
Q5RC51 | Pongo abelii | 25% | 80% |
Q8NA58 | Homo sapiens | 25% | 98% |
Q8VDG3 | Mus musculus | 26% | 82% |
Q8W4C3 | Arabidopsis thaliana | 21% | 83% |
Q90ZA1 | Xenopus laevis | 25% | 81% |
Q9LG26 | Arabidopsis thaliana | 23% | 74% |
V5ASU9 | Trypanosoma cruzi | 35% | 99% |
V5BCG2 | Trypanosoma cruzi | 27% | 100% |